Dr Palash Chandra Maity
Group Leader
| Cancer Research Institute
Ulm University
Bavaria
Expertise:
Immunology
34
Publications
7
Projects
147
Scopus Citations
794
CrossRef
9 Years 3 Months Total Experience
Scopus
147
Citations
6
h-index
CrossRef
794
Citations
14
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Max Planck Institute International Postdoctoral Fellowship
2010
Max Planck Institute of Immunobiology and Epigenetics
Council of Scientific and Industrial Research Fellowship
2005
Council of Scientific and Industrial Research, India
Graduate Aptitude Test for Engineering
2004
IIT Delhi
Indian Academy of Science Fellowship for External Project
2003
Indian Academy of Science, Bangalore, India
National Scholarship for Higher Education for M.Sc
2002
Ministry of HRD, India
Community & Membership
No Data Found
There is currently nothing to display here.
German Society for Immunology (DGfI)
MemberGerman University Association (DHV)
Member (Habilitation)Personal Details
Doctor of Philosophy
2010
Central Rice Research Institute
Master of Science
2004
Central Rice Research Institute
Chartered Accountancy
2003
N/A
Bachelor of Science
2002
Central Rice Research Institute
Group Leader
Jun 2022 – Present
Ulm University
| Cancer Research Institute
Research Fellow
Jan 2005 – Dec 2009
UNIVERSITY OF CALCUTTA
| Department of Biotechnology and Dr. B. C Guha Centre for Genetic Engineering and Biotechnology
Medical and Health Sciences
Scholarly Work
Antibody-based immunotherapy targeting BCR and coreceptor signaling pathways
OtherCharacterization of peptides targeting G-coupled receptors in hematological malignancies. Project B01, SFB 1279
CompletedDeveloping functional assay platforms for analysis of lymphoma models and clinical (CLL) samples
CompletedNanoscale organization of BCR complexes using super-resolution imaging and computational modeling
CompletedMolecular mechanisms of B cell receptor membrane organization and signaling
CompletedOxidative stress induced inflammation of lung epithelium, systemic implications extending to atherogenic damages, macrophage potentiation and protective role of dietary antioxidant
CompletedDNA Methylation Analysis of Imprinted Genes using Methylation Sensitive Restriction Enzyme
CompletedSignal Transduction of the B Cell Receptor in the context of the cytoskeleton and cross-talk with other receptors
MSc. Diploma:Class specific protein-interactions of the B cell antigen receptor on the plasma membrane
MSc Diploma: Proteomic investigation of B cell surface organization
The role of antigen receptor isotype in B cell development, humoral response and tolerance
MSc: Signaling capabilities of B-cell receptors derived from monoclonal B-lymphocytosis in comparison to chronic lymphocytic leukemia
MSc.: Role of CD19 mediated survival signal in B cell lymphoma
Essential Role of CD19 in CXCL12-CXCR4 signaling axis of B-cell Lymphoma
Animal model for cigarette-smoke-induced atherosclerosis and related methods
University of Calcutta
-
Patent No. :
US 8,541,645 B2
Filed :
30-11--0001
Published :
30-11--0001
Granted
Scholarly Publications
Control of B Cell Responsiveness by Isotype and Structural Elements of the Antigen Receptor
10.1016/j.it.2016.03.004
Crossref: 35
Facilitating Gene Editing in Human Lymphoma Cells Using Murine Ecotropic γ-Retroviruses
10.1007/978-1-0716-4442-3_10
Crossref: 1
Facilitating Gene Editing in Human Lymphoma Cells Using Murine Ecotropic γ-Retroviruses
Open AccessThe VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands
Open Access
10.1038/s41375-024-02376-7
Crossref: 7
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia.
Open Access
10.1172/jci149308
Crossref: 18
Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation.
Open Access
10.1002/jlb.1hi0621-313r
Crossref: 4
The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia.
Open Access
10.3389/fonc.2021.771669
Crossref: 4
Continuous signaling of CD 79b and CD 19 is required for the fitness of Burkitt lymphoma B cells
Open Access
10.15252/embj.201797980
Crossref: 69
Showing 1 to 8 of 34 publications